Danaher Corporation (NYSE:DHR) reported first-quarter results that beat earnings expectations but fell short on revenue, sending shares as much as 3.8% lower in premarket trading before a recovery, ...
Following a high-profile pressure campaign, the company that makes a crucial tuberculosis test has agreed to sell its product at cost to an international organization that works with low-income ...
When the plot was written for Sunnyvale's Cepheid, it was a classic tale of turning swords into plowshares. Founded in 1996, the fledgling biotech company took fast new methods of DNA analysis ...
SUNNYVALE, Calif. , Feb. 18, 2026 /PRNewswire/ -- Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results